Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-22-274966
Filing Date
2022-11-01
Accepted
2022-11-01 16:30:57
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d411751dsc13da.htm SC 13D/A 62784
  Complete submission text file 0001193125-22-274966.txt   64316
Mailing Address 8 RUE DE LA CROIX JARRY PARIS, LLE-DE-FRANCE I0 75013
Business Address 8 RUE DE LA CROIX JARRY PARIS, LLE-DE-FRANCE I0 75013 33181691600
Cellectis S.A. (Filed by) CIK: 0001627281 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 2800 MOUNT RIDGE ROAD ROSEVILLE MN 55113
Business Address 2800 MOUNT RIDGE ROAD ROSEVILLE MN 55113 (651) 683-2807
Calyxt, Inc. (Subject) CIK: 0001705843 (see all company filings)

EIN.: 271967997 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90065 | Film No.: 221350876
SIC: 2870 Agricultural Chemicals